Carna Biosciences, Inc. reported consolidated earnings results for the six months ended June 30, 2019. For the period, the company's net sales were JPY 2,460 million against JPY 399 million a year ago. Operating profit was JPY 1,451 million against loss of JPY 436 million a year ago. Profit was JPY 1,195,813,000 against loss of JPY 489,682,000 a year ago. Basic earnings per share were JPY 113.86 against loss of JPY 51.17 a year ago. Diluted earnings per share were JPY 112.54.

For full year ending December 31, 2019, the company expects consolidated net sales of JPY 3,038 million, operating income of JPY 313 million and profit attributable to owners of parent of JPY 214 million or JPY 20.12 per share.